Evidence map›Paper›PMID 33582965›Full record

SynthesisNeuropsychology review2021

Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.

Yuan Cao, Wei Diao, Fangfang Tian, Feifei Zhang, Laichang He, Xipeng Long, Fuqinq Zhou, Zhiyun Jia

Erratum issuedAbstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Neuropsychology review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. The effect of ibudilast on thalamic volume in progressive multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2023
    Trial
  5. Neuroprotective Role of Cannabinoid CBMolecular neurobiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Heteromers Formed by GPR55 and Either Cannabinoid CBInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuan Cao *Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Wei Diao *Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Fangfang TianDepartment of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Feifei ZhangHuaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, 610041, China.
Laichang HeDepartment of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, 330001, China.
Xipeng LongDepartment of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Fuqinq ZhouDepartment of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, 330001, China.
Zhiyun JiaDepartment of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China. zhiyunjia@hotmail.com.ORCID 0000-0003-1886-5654
Sichuan University · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gray matter atrophy in multiple sclerosis (MS) is thought to be associated with disability and cognitive impairment, but previous studies have sometimes had discordant results, and the atrophy patterns of relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS) remain to be clarified. We conducted a meta-analysis using anisotropic effect-size-based algorithms (AES-SDM) to identify consistent findings from whole-brain voxel-based morphometry (VBM) studies of gray matter volume (GMV) in 924 RRMS patients and 204 PPMS patients. This study is registered with PROSPERO (number CRD42019121319). Compared with healthy controls, RRMS and PPMS patients showed gray matter atrophy in the cortico-striatal-thalamic network, sensorimotor network, and bilateral insula. RRMS patients had a larger GMV in the left insula, cerebellum, right precentral gyrus, and bilateral putamen as well as a smaller GMV in the bilateral cingulate, caudate nucleus, right thalamus, superior temporal gyrus and left postcentral gyrus than PPMS patients. The disease duration, Expanded Disability Status Scale score, Paced Auditory Serial Addition Test z-score, and T2-weighted lesion load were associated with specific gray matter regions in RRMS or PPMS. Alterations in the cortico-striatal-thalamic networks, sensorimotor network, and insula may be involved in the common pathogenesis of RRMS and PPMS. The deficits in the cingulate gyrus and caudate nucleus are more apparent in RRMS than in PPMS. The more severe cerebellum atrophy in PPMS may be a brain feature associated with its neurological manifestations. These imaging biomarkers provide morphological evidence for the pathophysiology of MS and should be verified in future research.

Indexed as

Multiple SclerosisMultiple Sclerosis, Chronic ProgressiveAtrophyBrainGray MatterHumansMagnetic Resonance ImagingThalamusCortico-striatal-thalamic networksGray matter atrophyMultiple sclerosisSensorimotor network

Identifiers

PMID33582965
OpenAlexW3132933876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.